The National Health Service is the United Kingdom’s largest employer, committed to delivering high quality, safe healthcare, and dependent on an engaged, properly resourced workforce to cope with ever rising […]
Month: May 2018
Processing trauma: Resilience may not lie within individuals, but between individuals
Matthew Walton discusses the importance of education and peer support in medical school […]
Kent Buse and Sarah Hawkes: Gender—global health’s dirty little secret
All global health organisations need to understand how gender dynamics impact on the health outcomes of both women and men—as well as on their staffing […]
Matthew Taylor: People not technology will shape the future of work
As the author of “Good Work”, the report of the independent inquiry into modern employment practices commissioned in 2016 by the prime minister, I often speak at conferences exploring the […]
Unreported clinical trial of the week: Brexpiprazole for treatment of patients with agitation associated with Alzheimer’s (NCT01922258)
Nick DeVito and Ben Goldacre Background The US FDA Amendments Act (FDAAA 2007) requires certain clinical trials to report their results onto ClinicalTrials.gov within one year of completion. Our FDAAA TrialsTracker shows […]
J T Winkler and Tam Fry: Making the healthy choice the cheaper choice
The Soft Drinks Industry Levy (SDIL) is already showing some signs of success. Indeed, a double success—not just lowering the sugar content of drinks, but lowering the comparative prices of […]
Richard Lehman’s journal review—14 May 2018
Richard Lehman reviews the latest research in the top medical journals […]
Peter Brindley: Thank God for science
Science is often given short shrift because it is hard work, and makes our collective heads hurt. In a world where objective truth receives a daily thrashing we need to […]
Even normal saline is harmful if used wrongly, so why did EMA single out hydroxyethyl starch?
The European Medicines Agency (EMA) has recommended the suspension of hydroxyethyl starch (HES) solutions from the market—a cornerstone treatment for hypovolemia. Such a recommendation makes no sense, for it is […]
Jeffrey Aronson: When I use a word . . . Amerilexicophobia and drug names
Amerilexicophobia, the fear, dislike, or even hatred of linguistic Americanisms, has two main targets: spelling, one particular aspect of which I discussed last week, and words and terms whose meanings […]